Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million
12/05/2026 21:07
May 12 (Reuters) - Interpace Biosciences Q1 operating income USD 1.123 million. Q1 gross profit USD 5.904 million Q1 net income USD 721 thousand Q1 operating expenses USD 4.781 million